RxDoctor Payments Data

Kelly Crenshaw

Psychiatric/Mental Health · Raleigh, NCNPI 1790161263

Payments from drug & device makers

$3,085in general payments, 2019–2025

Across 175 payments — averaging $17.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$844
  • AbbVie$297
  • Lundbeck LLC$214
  • Axsome Therapeutics, Inc.$203
  • Otsuka America Pharmaceutical, Inc.$189
  • Tris Pharma Inc$150
  • plus $1K from 19 others

What the payments were for

  • Food & beverage$3,085100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,085 in reported general payments places this provider in the 85th percentile of 947 psychiatric/mental health providers in North Carolina.

See all psychiatric/mental health providers in North Carolina

Medicare billing

Part B allowed, 2024
$16,339
Medicare patients
26
Services billed
200

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
VraylarCariprazine Hcl11$29,891
CaplytaLumateperone Tosylate12$19,240
Duloxetine Hcl39$1,750
Venlafaxine Hcl ErVenlafaxine Hcl27$1,255
Mirtazapine44$1,078
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine42$1,004
Bupropion XlBupropion Hcl51$980
Clonazepam110$919
Desvenlafaxine Succinate ErDesvenlafaxine Succinate16$903
Aripiprazole41$898
Gabapentin39$893
Methylphenidate ErMethylphenidate Hcl11$818
Lamotrigine52$622
Fluoxetine Hcl42$533
Hydroxyzine Hcl21$485

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieVraylar$297$29,89111 claims
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)Caplyta$844$19,24012 claims
Almatica Pharma LLCSertraline Hcl$98$26324 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 947 psychiatric/mental health providers in North Carolina.

Other psychiatric/mental health in Raleigh

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →